These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 22947347

  • 1. Long-term 3,5,3'-triiodothyroacetic acid therapy in a child with hyperthyroidism caused by thyroid hormone resistance: pharmacological study and therapeutic recommendations.
    Anzai R, Adachi M, Sho N, Muroya K, Asakura Y, Onigata K.
    Thyroid; 2012 Oct; 22(10):1069-75. PubMed ID: 22947347
    [Abstract] [Full Text] [Related]

  • 2. Prenatal diagnosis of thyroid hormone resistance.
    Asteria C, Rajanayagam O, Collingwood TN, Persani L, Romoli R, Mannavola D, Zamperini P, Buzi F, Ciralli F, Chatterjee VK, Beck-Peccoz P.
    J Clin Endocrinol Metab; 1999 Feb; 84(2):405-10. PubMed ID: 10022392
    [Abstract] [Full Text] [Related]

  • 3. Clinical and hormonal outcome after two years of triiodothyroacetic acid treatment in a child with thyroid hormone resistance.
    Radetti G, Persani L, Molinaro G, Mannavola D, Cortelazzi D, Chatterjee VK, Beck-Peccoz P.
    Thyroid; 1997 Oct; 7(5):775-8. PubMed ID: 9349583
    [Abstract] [Full Text] [Related]

  • 4. Differences in response of thyrotropin to 3,5,3'-triiodothyronine and 3,5,3'-triiodothyroacetic acid in patients with resistance to thyroid hormone.
    Ueda S, Takamatsu J, Fukata S, Tanaka K, Shimizu N, Sakata S, Yamaji T, Kuma K, Ohsawa N.
    Thyroid; 1996 Dec; 6(6):563-70. PubMed ID: 9001190
    [Abstract] [Full Text] [Related]

  • 5. 9 years follow-up of a patient with pituitary form of resistance to thyroid hormones (PRTH): comparison of two treatment periods of D-thyroxine and triiodothyroacetic acid (TRIAC).
    Guran T, Turan S, Bircan R, Bereket A.
    J Pediatr Endocrinol Metab; 2009 Oct; 22(10):971-8. PubMed ID: 20020587
    [Abstract] [Full Text] [Related]

  • 6. 3,5,3'-triiodothyroacetic acid therapy for thyroid hormone resistance.
    Kunitake JM, Hartman N, Henson LC, Lieberman J, Williams DE, Wong M, Hershman JM.
    J Clin Endocrinol Metab; 1989 Aug; 69(2):461-6. PubMed ID: 2753985
    [Abstract] [Full Text] [Related]

  • 7. Endocrine and neuropsychological assessment in a child with a novel mutation of thyroid hormone receptor: response to 12-month triiodothyroacetic acid (TRIAC) therapy.
    Torre P, Bertoli M, Di Giovanni S, Scommegna S, Conte C, Novelli G, Cianfarani S.
    J Endocrinol Invest; 2005 Aug; 28(7):657-62. PubMed ID: 16218051
    [Abstract] [Full Text] [Related]

  • 8. Successful therapy with 3,5,3'-triiodothyroacetic acid (TRIAC) in pituitary resistance to thyroid hormone.
    Darendeliler F, Baş F.
    J Pediatr Endocrinol Metab; 1997 Aug; 10(5):535-8. PubMed ID: 9401912
    [No Abstract] [Full Text] [Related]

  • 9. Therapeutic applications of thyroid hormone analogues in resistance to thyroid hormone (RTH) syndromes.
    Groeneweg S, Peeters RP, Visser TJ, Visser WE.
    Mol Cell Endocrinol; 2017 Dec 15; 458():82-90. PubMed ID: 28235578
    [Abstract] [Full Text] [Related]

  • 10. A child with resistance to thyroid hormone without thyroid hormone receptor gene mutation: a 20-year follow-up.
    Hamon B, Hamon P, Bovier-Lapierre M, Pugeat M, Savagner F, Rodien P, Orgiazzi J.
    Thyroid; 2008 Jan 15; 18(1):35-44. PubMed ID: 18302516
    [Abstract] [Full Text] [Related]

  • 11. TRIAC (3,5,3'-triiodothyroacetic acid) has parallel effects at the pituitary and peripheral tissue levels in thyroid cancer patients treated with L-thyroxine.
    Mechelany C, Schlumberger M, Challeton C, Comoy E, Parmentier C.
    Clin Endocrinol (Oxf); 1991 Aug 15; 35(2):123-8. PubMed ID: 1934526
    [Abstract] [Full Text] [Related]

  • 12. Effective TRIAC treatment of a THRβ-mutated patient with thyroid hormone resistance.
    Carbone A, Verrienti A, Cito DS, Sponziello M, Pecce V, Bruno R.
    Endocrine; 2024 Aug 15; 85(2):598-600. PubMed ID: 38558372
    [Abstract] [Full Text] [Related]

  • 13. [Hyperthyroidism caused by inadequate TSH secretion].
    Zass R, Steindor U, Wendel U.
    Monatsschr Kinderheilkd; 1993 Feb 15; 141(2):100-2. PubMed ID: 7681522
    [Abstract] [Full Text] [Related]

  • 14. Assessing the clinical and molecular diagnosis of inherited forms of impaired sensitivity to thyroid hormone from a single tertiary center.
    Ramos LS, Kizys MML, Kunii IS, Spinola-Castro AM, Nesi-França S, Guerra RA, Camacho CP, Martins JRM, Maciel RMB, Dias-da-Silva MR, Chiamolera MI.
    Endocrine; 2018 Dec 15; 62(3):628-638. PubMed ID: 30027432
    [Abstract] [Full Text] [Related]

  • 15. Successful every-other-day liothyronine therapy for severe resistance to thyroid hormone beta with a novel THRB mutation; case report.
    Maruo Y, Mori A, Morioka Y, Sawai C, Mimura Y, Matui K, Takeuchi Y.
    BMC Endocr Disord; 2016 Jan 12; 16():1. PubMed ID: 26754848
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the metabolic and endocrine effects of 3,5,3'-triiodothyroacetic acid and thyroxine.
    Bracco D, Morin O, Schutz Y, Liang H, Jéquier E, Burger AG.
    J Clin Endocrinol Metab; 1993 Jul 12; 77(1):221-8. PubMed ID: 8325946
    [Abstract] [Full Text] [Related]

  • 17. Diabetes mellitus in a girl with thyroid hormone resistance syndrome: a little recognized interaction between the two diseases.
    Stagi S, Manoni C, Cirello V, Covelli D, Giglio S, Chiarelli F, Seminara S, de Martino M.
    Hormones (Athens); 2014 Jul 12; 13(4):561-7. PubMed ID: 25402385
    [Abstract] [Full Text] [Related]

  • 18. Bromocriptine and Triac therapy for hyperthyroidism due to pituitary resistance to thyroid hormone.
    Dulgeroff AJ, Geffner ME, Koyal SN, Wong M, Hershman JM.
    J Clin Endocrinol Metab; 1992 Oct 12; 75(4):1071-5. PubMed ID: 1400873
    [Abstract] [Full Text] [Related]

  • 19. Thyroid Hormone Resistance in children.
    Ercan O.
    Pediatr Endocrinol Rev; 2003 Dec 12; 1 Suppl 2():191-8; discussion 198. PubMed ID: 16444158
    [Abstract] [Full Text] [Related]

  • 20. Behavioral effects of liothyronine (L-T3) in children with attention deficit hyperactivity disorder in the presence and absence of resistance to thyroid hormone.
    Weiss RE, Stein MA, Refetoff S.
    Thyroid; 1997 Jun 12; 7(3):389-93. PubMed ID: 9226208
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.